ask="N/A"
ask_size="N/A"
average_daily_volume="263420"
bid="25.00"
bid_size="100"
book_value="6.63"
change="-0.79"
change_from_200_day_moving_average="0.12"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-7.59"
change_From_52_week_low="16.33"
change_in_percent="-2.46%"
close="31.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.26"
ebitda="-177.35M"
eps_estimate_current_year="-4.40"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="30821000"
high="32.01"
high_52_weeks="38.92"
last_trade_date="3/6/2017"
last_trade_price="31.33"
last_trade_size="15351"
last_trade_time="4:00pm"
low="31.24"
low_52_weeks="15.00"
market_capitalization="1.66B"
moving_average_200_day="31.21"
moving_average_50_day="31.07"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.86"
open="31.87"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+0.39%"
percent_change_from_50_day_moving_average="+0.84%"
percent_change_from_52_week_high="-19.50%"
percent_change_from_52_week_low="+108.87%"
previous_close="32.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.85"
price_per_sales="34.90"
revenue="48.65M"
shares_outstanding="52855000"
short_ratio="26.94"
stock_exchange="NGM"
symbol="TBPH"
volume="248037"
weeks_range_52="15.00 - 38.92"
